<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExclusivity_period</id>
	<title>Definition:Exclusivity period - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AExclusivity_period"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity_period&amp;action=history"/>
	<updated>2026-05-02T13:45:26Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity_period&amp;diff=17635&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Exclusivity_period&amp;diff=17635&amp;oldid=prev"/>
		<updated>2026-03-15T15:33:02Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;⏳ &amp;#039;&amp;#039;&amp;#039;Exclusivity period&amp;#039;&amp;#039;&amp;#039; is the contractually defined window of time during which a seller in an [[Definition:Insurance merger and acquisition (M&amp;amp;A) | insurance M&amp;amp;A]] process agrees not to negotiate with, solicit, or accept offers from any party other than the designated prospective buyer. Typically established through an [[Definition:Exclusivity letter | exclusivity letter]] or a clause within a [[Definition:Letter of intent (LOI) | letter of intent]], this period gives the buyer protected time to conduct [[Definition:Due diligence | due diligence]], negotiate definitive agreements, and secure necessary internal or [[Definition:Regulatory approval | regulatory]] approvals without the threat of a competing transaction.&lt;br /&gt;
&lt;br /&gt;
⚙️ In insurance transactions, exclusivity periods commonly range from four to twelve weeks, though the duration depends on the complexity of the target. A straightforward acquisition of an [[Definition:Insurance brokerage | insurance brokerage]] with fee-based revenue may require only a short window, while the purchase of an [[Definition:Insurance carrier | insurance carrier]] with [[Definition:Long-tail liability | long-tail]] liabilities, multi-jurisdictional [[Definition:Reinsurance | reinsurance]] programs, and regulatory change-of-control requirements across several markets may demand a substantially longer period. The exclusivity window often includes negotiated extension provisions — triggered, for instance, if the buyer is still awaiting a regulatory response from a body such as a U.S. state insurance department, the [[Definition:Prudential Regulation Authority (PRA) | UK PRA]], or the [[Definition:Monetary Authority of Singapore (MAS) | MAS]] at the time of expiry. Critically, the period is usually subject to early termination if either party fails to negotiate in good faith or if specific deal-breakers emerge during diligence.&lt;br /&gt;
&lt;br /&gt;
🔑 The length and terms of the exclusivity period often signal the seriousness of both parties&amp;#039; commitment. Buyers who invest in expensive [[Definition:Actuarial analysis | actuarial]] reviews, [[Definition:Loss reserve | reserve]] studies, and regulatory pre-clearance need assurance that the seller will not use their findings as leverage to reopen the process to competitors. Sellers, on the other hand, balance the value of deal certainty against the risk that a prolonged exclusivity window keeps other qualified buyers on the sidelines while market conditions shift. In consolidating segments of the insurance market — such as the U.S. [[Definition:Property and casualty insurance | property-casualty]] agency space or the European [[Definition:Insurtech | insurtech]] sector — where multiple potential acquirers may be circling, the negotiation of the exclusivity period can be as commercially significant as the headline [[Definition:Purchase price | valuation]] itself.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Exclusivity letter]]&lt;br /&gt;
* [[Definition:Letter of intent (LOI)]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Regulatory approval]]&lt;br /&gt;
* [[Definition:Expression of interest (EOI)]]&lt;br /&gt;
* [[Definition:No-shop clause]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>